Tommi Remonen

Tommi Remonen is an experienced professional in the field of organic chemistry and innovative materials, currently serving as the CTO and Co-founder of Agteria Biotech since November 2023 and the Founder of AmmoniQ, focused on developing an electrochemical route to ammonia since April 2023. Additionally, Tommi owns AX Development AB and RAK investering Ab, specializing in early-stage investments in innovative companies. Previously, Tommi held various roles, including Business Owner at MIDax AB, Senior Scientist at Graphmatech, and Co-founder of Arubedo AB, which specializes in organoelectronics. As CTO and Principal Scientist at Disruptive Materials AB, Tommi advanced the development of Upsalite® for customer-specific applications. Tommi's career also includes strategic roles at Chemtronica AB and MedChemtronica AB, along with academic credentials including a Ph.D. in Organic Chemistry from KTH Royal Institute of Technology.